1-866-598-7166

News

KIdney cancer clinical trial

Two new studies added to the list of clinical trials

Trial ID : NCT05043090
Kidney Cancer Type: Papillary
A study of combination durvalamab + savolitinib versus sunitinib or durvalamab alone in patients with papillary kidney cancer

view trial page

Basic Eligibility:

  • Papillary kidney cancer
  • Advanced kidney cancer that cannot be removed by surgery
  • Genetic test required to confirm c-MET is involved in driving your cancer
  • No prior treatment is allowed with any of the study drugs, or any other c-MET inhibitor (e.g. Cabozantinib)

Trial ID : NCT04987203
Kidney Cancer Type: Clear Cell
A study of tivozanib alone or in combination with nivolumab in patients with advanced kidney cancer

view trial page

Basic Eligibility:

  • Clear Cell Kidney Cancer Only
  • Advanced kidney cancer that cannot be removed by surgery
  • Patients must have completed at least one line of prior immunotherapy (e.g. Pembrolizumab)
Kidney Cancer Canada